A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin +10 more·2005·Nature Medicine

Cited by (1,001)

Items 101–200 of 1,001

  1. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
    Helga Eyjolfsdottir, Maria Eriksdotter, Bengt Linderoth, Göran Lind, Bengt Juliusson, Philip Kusk, Ove Almkvist, Niels Andreasen, Kaj Blennow, Daniel Ferreira et al. · 2016 · Alzheimer s Research & Therapy
  2. Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation
    Peixin Liu, Tongyu Zhang, Qinjun Chen, Chao Li, Yongchao Chu, Qin Guo, Yiwen Zhang, Wenxi Zhou, Hongyi Chen, Zheng Zhou et al. · 2021 · Advanced Materials
  3. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.
    Jisook Moon, May W. Chen, Shruti U. Gandhy, Myla S. Strawderman, David A. Levitsky, Kenneth N. Maclean, Barbara J. Strupp · 2010 · Behavioral Neuroscience
  4. TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease
    Filippo Caraci, Giuseppe Battaglia, Valeria Bruno, Paolo Bosco, Viviana Carbonaro, Maria Laura Giuffrida, Filippo Drago, Maria Angela Sortino, Ferdinando Nicoletti, Agata Copani · 2009 · CNS Neuroscience & Therapeutics
  5. Non-Viral Gene Delivery to Mesenchymal Stem Cells: Methods, Strategies and Application in Bone Tissue Engineering and Regeneration
    José Luís Santos, Deepti Pandita, João Rodrigues, Ana Paula Pêgo, Pedro Lopes Granja, Helena Tomás · 2011 · Current Gene Therapy
  6. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
    M. Florencia Iulita, A. Claudio Cuello · 2014 · Trends in Pharmacological Sciences
  7. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex
    Adrian P. Kells, Piotr Hadaczek, Dali Yin, John Bringas, Vanja Varenika, John Forsayeth, Krystof S. Bankiewicz · 2009 · Proceedings of the National Academy of Sciences
  8. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases
    Barchet, Thomas M, Amiji, Mansoor M · 2009 · Expert Opinion on Drug Delivery
  9. The effect of collagen-binding NGF-β on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model
    Wenjie Sun, Changkai Sun, Hang Lin, Hui Zhao, Jingyu Wang, Hui Ma, Bing Chen, Zhifeng Xiao, Jianwu Dai · 2009 · Biomaterials
  10. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment
    Michel J. Grothe, Helmut Heinsen, Edson Amaro, Lea T. Grinberg, Stefan Johannes Teipel · 2015 · Cerebral Cortex
  11. The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons
    Duygu Gezen‐Ak, Erdinç Dursun, Selma Yılmazer · 2011 · PLoS ONE
  12. Numerical study of a simple transcranial focused ultrasound system applied to blood-brain barrier opening
    Thomas Deffieux, Elisa E. Konofagou · 2010 · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control
  13. Convection‐Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
    Neil U. Barua, Steven S. Gill, Seth Love · 2013 · Brain Pathology
  14. Progress in Stem Cell Therapy for Major Human Neurological Disorders
    Patricia Martínez‐Morales, A. Revilla, I. Ocaña, Clara González, P. Sainz, Daniel McGuire, Isabel Liste · 2013 · Stem Cell Reviews and Reports
  15. Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
    Verica Vasić, Kathrin Barth, Mirko H. H. Schmidt · 2019 · International Journal of Molecular Sciences
  16. Self-Assembling Hydrogel Structures for Neural Tissue Repair
    Sofia Peressotti, Gillian E. Koehl, Josef A. Goding, Rylie A. Green · 2021 · ACS Biomaterials Science & Engineering
  17. Viral vectors for neurotrophic factor delivery: A gene therapy approach for neurodegenerative diseases of the CNS
    Seung Taik LIM, Mikko Airavaara, Brandon K. Harvey · 2009 · Pharmacological Research
  18. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders
    Ronald J. Mandel, Fredric P. Manfredsson, Kevin D. Foust, Aaron C. Rising, Sharon Reimsnider, Kevin R. Nash, Corinna Bürger · 2006 · Molecular Therapy
  19. Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery
    Lars U. Wahlberg, Göran Lind, Per M. Almqvist, Philip Kusk, Jens Tornøe, Bengt Juliusson, Michael Söderman, Eva Selldén, Åke Seiger, Maria Eriksdotter et al. · 2012 · Journal of neurosurgery
  20. Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice
    Lori A. Lebson, Kevin R. Nash, Siddharth G. Kamath, Donna L. Herber, Nikisha Carty, Daniel C. Lee, Q. Li, Károly Szekeres, Umesh K. Jinwal, John Koren et al. · 2010 · Journal of Neuroscience
  21. From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
    Claire Géral, Angelina Angelova, Sylviane Lesieur · 2013 · Pharmaceutics
  22. Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
    Zhao, Hailin, Alam, Azeem, San, Chun-Yin, Eguchi, Shiori, Chen, Qian, Lian, Qingquan, Ma, Daqing · 2017 · Brain Research
  23. Current therapeutic targets for the treatment of Alzheimer’s disease
    Joshua D. Grill, Jeffrey L. Cummings · 2010 · Expert Review of Neurotherapeutics
  24. Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease
    Matthew L. Hemming, Michaela Patterson, Casper Reske-Nielsen, Ling Lin, Ole Isacson A, Dennis J. Selkoe · 2007 · PLoS Medicine
  25. Adeno-Associated Viral Vectors in Neuroscience Research
    David L. Haggerty, Gregory G. Grecco, Kaitlin C. Reeves, Brady K. Atwood · 2019 · Molecular Therapy — Methods & Clinical Development
  26. Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery
    Michael J. Castle, Fernando C. Baltanás, Imre Kovács, Alan H. Nagahara, David Barba, Mark H. Tuszynski · 2020 · Human Gene Therapy
  27. Endosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases
    Francisca C. Bronfman, Claudia A. Escudero, Joachim Weis, Alex Krüttgen · 2007 · Developmental Neurobiology
  28. A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
    Juliet K. Knowles, Danielle A. Simmons, Thuy‐Vi V. Nguyen, Lilith Vander Griend, Youmei Xie, Hong Zhang, Tao Yang, Julia Pollak, Timothy Chang, Ottavio Arancio et al. · 2013 · Neurobiology of Aging
  29. Neurotrophins and Proneurotrophins: Focus on Synaptic Activity and Plasticity in the Brain
    Gibon, Julien, Barker, Philip A. · 2017 · The Neuroscientist
  30. Disease modifying therapy for AD?<sup>1</sup>
    Golde, Todd E. · 2006 · Journal of Neurochemistry
  31. Nerve growth factor therapy for corneal disease
    Alessandro Lambìase, Marta Sacchetti, Stefano Bonini · 2012 · Current Opinion in Ophthalmology
  32. Apoptosis and in vitro Alzheimer’s disease neuronal models
    Pietro Calissano, Carmela Matrone, Giuseppina Amadoro · 2009 · Communicative & Integrative Biology
  33. A Novel Endocytic Recycling Signal Distinguishes Biological Responses of Trk Neurotrophin Receptors
    Zhe-Yu Chen, Alessandro Ieraci, Michael Tanowitz, Francis S. Lee · 2005 · Molecular Biology of the Cell
  34. Novel insights for the treatment of Alzheimer's disease
    Alexander Kurz, Robert Perneczky · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  35. Altered synaptic function in Alzheimer's disease
    Karen F. S. Bell, A. Claudio Cuello · 2006 · European Journal of Pharmacology
  36. Gene therapy and transplantation in CNS repair: The visual system
    Alan R. Harvey, Ying Jia Hu, Simone G. Leaver, Carla Mellough, Kevin Kyungsuk Park, Joost Verhaagen, Giles W. Plant, Qi Cui · 2006 · Progress in Retinal and Eye Research
  37. The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
    A. Claudio Cuello, Rowan Pentz, Hélène Hall · 2019 · Frontiers in Neuroscience
  38. Neuroregeneration in neurodegenerative disorders
    Ana‐Maria Enciu, Mihnea Ioan Nicolescu, Catalin Gabriel Manole, Dafin Fior Muresanu, Laurentiu Mircea Popescu, Bogdan Ovidiu Popescu · 2011 · BMC Neurology
  39. Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review
    Sandeep Kumar Vishwakarma, Avinash Bardia, Santosh Kumar Tiwari, Syed Ameer Basha Paspala, Aleem Ahmed Khan · 2013 · Journal of Advanced Research
  40. Assessing the quality of democratic deliberation: A case study of public deliberation on the ethics of surrogate consent for research
    Raymond G. De Vries, Aimee Stanczyk, Ian F. Wall, Rebecca A. Uhlmann, Laura J. Damschroder, Scott Y. H. Kim · 2010 · Social Science & Medicine
  41. The anti-amnesic effects of luteolin against amyloid β25–35 peptide-induced toxicity in mice involve the protection of neurovascular unit
    R. Liu, Mingyue Gao, Guifen Qiang, T.-T. Zhang, Xi Lan, Jian Ying, G.-H. Du · 2009 · Neuroscience
  42. Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis
    John F. Hines, M. Groll, Margaret L. Fahnestock, Craig M. Crews · 2008 · Chemistry & Biology
  43. Gain of BDNF Function in Engrafted Neural Stem Cells Promotes the Therapeutic Potential for Alzheimer’s Disease
    Cheng‐Chun Wu, Cheng‐Chang Lien, Wen‐Hsien Hou, Po‐Min Chiang, Kuen‐Jer Tsai · 2016 · Scientific Reports
  44. NGF steers microglia toward a neuroprotective phenotype
    Caterina Rizzi, Alexia Tiberi, Michela Giustizieri, Maria Cristina Marrone, Francesco Gobbo, Nicola Maria Carucci, Giovanni Meli, Ivan Arisi, Mara D’Onofrio, Silvia Marinelli et al. · 2018 · Glia
  45. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives
    Yousra El Ouaamari, Jasper Van den Bos, Barbara M. P. Willekens, Nathalie Cools, Inez Wens · 2023 · International Journal of Molecular Sciences
  46. Astrocyte–neuron interplay in maladaptive plasticity.
    Papa, Michele, De Luca, Ciro, Petta, Federica, Alberghina, Lilia, Cirillo, Giovanni · 2014 · Neuroscience &amp; Biobehavioral Reviews
  47. Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
    Elliott J. Mufson, Scott Counts, Margaret L. Fahnestock, Stephen D. Ginsberg · 2007 · Current Alzheimer Research
  48. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management.
    Parris M. Kidd · 2005 · PubMed
  49. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice
    Nobuaki Matsui, Kazuki Takahashi, Miho Takeichi, Touma Kuroshita, Kaori Noguchi, Kana Yamazaki, Hideaki Tagashira, Kenichi Tsutsui, Hideki Okada, Yuki Kido et al. · 2009 · Brain Research
  50. Back to the Future with Phenotypic Screening
    Marguerite Prior, Chandramouli Chiruta, Antonio Jose Martins Currais, Josh Goldberg, Justin Ramsey, Richard Dargusch, Pamela A Maher, David A. Schubert · 2014 · ACS Chemical Neuroscience
  51. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
    Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
  52. Neurotrophins and acupuncture
    Luigi Manni, Marcello Albanesi, Morena Guaragna, Samuele Barbaro Paparo, Luigi Aloe · 2010 · Autonomic Neuroscience
  53. Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
    Hongqi Yang, Zhikun Sun, Shengdi Chen · 2012 · Translational Neurodegeneration
  54. Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function
    Miguel Mendivil‐Perez, Viviana Soto‐Mercado, Ana Guerra‐Librero, Beatriz I. Fernández-Gil, Javier Florido, Yingqiang Shen, Miguel Angel Tejada, Vivian Capilla‐González, Iryna Rusanova, José Manuel García‐Verdugo et al. · 2017 · Journal of Pineal Research
  55. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration
    Jianqing Gao, Yusuke Eto, Yasuo Yoshioka, Fumiko Sekiguchi, Shinnosuke Kurachi, Tomohiro Morishige, Xinglei Yao, Hikaru Watanabe, Ratima Asavatanabodee, Fuminori Sakurai et al. · 2007 · Journal of Controlled Release
  56. Behavior of neural stem cells in the Alzheimer brain
    Ben Waldau, Ashok Kumar Shetty · 2008 · Cellular and Molecular Life Sciences
  57. Lacunes: Small, deep cerebral infarcts
    C. Miller Fisher · 2011 · Neurology
  58. The World of Dementia Beyond 2020
    Henry Brodaty, Monique M.B. Breteler, Steven Trent DeKosky, Pascale Dorenlot, Laura Fratiglioni, Christoph Höck, Paul-Ariel Kenigsberg, Philip Scheltens, Bart De Strooper · 2011 · Journal of the American Geriatrics Society
  59. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
    Bartus, Raymond T., Johnson, Eugene M. · 2017 · Neurobiology of Disease
  60. Why Vitamin D in Alzheimer's Disease? The Hypothesis
    Duygu Gezen‐Ak, Selma Yılmazer, Erdinç Dursun · 2014 · Journal of Alzheimer s Disease
  61. Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease
    Klaus Heese, Jin Wei Low, Noriko Inoue · 2006 · Neurosignals
  62. Angels and demons: neurotrophic factors and epilepsy
    Michele Simonato, Enrico Tongiorgi, Mérab Kokaia · 2006 · Trends in Pharmacological Sciences
  63. Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an APP/PS1 Double Transgenic Model of Alzheimer’s Disease
    Wei Zhang, Peijun Wang, Hongying Sha, Jiong Ni, Minghua Li, Guo-jun Gu · 2014 · Molecular Neurobiology
  64. Nerve Growth Factor Gene Therapy in Alzheimer Disease
    Mark H. Tuszynski · 2007 · Alzheimer Disease & Associated Disorders
  65. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers
    Luigi Aloe, Paola Tirassa, Alessandro Lambìase · 2008 · Pharmacological Research
  66. Gene therapy for leukodystrophies
    Alessandra Biffi, Patrick R. Aubourg, Nathalie Cartier · 2011 · Human Molecular Genetics
  67. Progress and Prospects: Gene Therapy Clinical Trials (Part 2)
    Uta Griesenbach D · 2007 · Gene Therapy
  68. Electrical stimulation promotes nerve growth factor-induced neurite outgrowth and signaling
    Yu‐Jung Chang, Che-Ming Hsu, Chia‐Hua Lin, Michael Shiang-Cheng Lu, Linyi Chen · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
  69. IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice
    Tiffany J. Mellott, Sarah M. Pender, Rebecca M. Burke, Erika A. Langley, Jan Krzysztof Blusztajn · 2014 · PLoS ONE
  70. Neurotrophic Factors and Their Potential Applications in Tissue Regeneration
    Xiao, Nan, Le, Quynh-Thu · 2016 · Archivum Immunologiae et Therapiae Experimentalis
  71. One Hundred Years after the Discovery of Alzheimer's Disease. A Turning Point for Therapy?
    Ezio Giacobini, Robert E. Becker · 2007 · Journal of Alzheimer s Disease
  72. Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease
    Antonino Cattaneo, Simona Capsoni, Francesca Paoletti · 2008 · Journal of Alzheimer s Disease
  73. Human Neural Stem Cells Overexpressing Choline Acetyltransferase Restore Cognitive Function of Kainic Acid-Induced Learning and Memory Deficit Animals
    Dongsun Park, Seong Soo Joo, Tae Kyoung Kim, Sun Hee Lee, Hyomin Kang, Hong Jun Lee, Inja Lim, Akinori Matsuo, Ikuo Tooyama, Yun-Bae Kim et al. · 2011 · Cell Transplantation
  74. Gene therapy in Alzheimer’s disease – potential for disease modification
    Per Nilsson, Nobuhisa Iwata, Shin‐ichi Muramatsu, Lars O. Tjernberg, Bengt G. Winblad, Takaomi C. Saido · 2010 · Journal of Cellular and Molecular Medicine
  75. Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
    Eric N. Momin, Ahmed Mohyeldin, Hasan A. Zaidi, Guillermo Vela, Alfredo Quiñones‐Hinojosa · 2010 · Current Stem Cell Research & Therapy
  76. Nerve growth factor: basic studies and possible therapeutic applications
    Luigi Manni, Maria Luisa Rocco, Patrizia Bianchi, Marzia Soligo, Morena Guaragna, Samuele Paparo Barbaro, Luigi Aloe · 2013 · Growth Factors
  77. Disease-Modifying Therapies in Alzheimer???s Disease
    Michael H ll, Thomas Berger, Michael Thomas Heneka · 2006 · Drugs
  78. Genetic modification of stem cells for transplantation.
    M. Phillips, Yao-Liang Tang · 2008 · Advanced Drug Delivery Reviews
  79. Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons
    Kathie M. Bishop, Eva K. Hofer, Arpesh Mehta, Anthony Ramirez, Liangwu Sun, Mark H. Tuszynski, Raymond T. Bartus · 2008 · Experimental Neurology
  80. Human Neural Stem Cells Genetically Modified to Express Human Nerve Growth Factor (NGF) Gene Restore Cognition in the Mouse with Ibotenic Acid-Induced Cognitive Dysfunction
    Hong Jun Lee, In J. Lim, Seung W. Park, Yun B. Kim, Yong Ko, Seung Up Kim · 2012 · Cell Transplantation
  81. Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease
    Elliott Jay Mufson, Scott Counts, Stephen D. Ginsberg, Laura J. Mahady, Sylvia E. Perez, Stephen M. Massa, Frank M. Longo, Miloš D. Ikonomović · 2019 · Frontiers in Neuroscience
  82. Development of a Non Invasive NGF-Based Therapy for Alzheimers Disease
    Sonia Covaceuszach, Simona Capsoni, Gatsuella Ugolini, Francesca Spirito, Domenico Vignone, Antonino Cattaneo · 2009 · Current Alzheimer Research
  83. Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies
    Adam L. Boxer, Bradley F. Boeve · 2007 · Alzheimer Disease & Associated Disorders
  84. Growth factor and stem cell enhanced conduits in peripheral nerve regeneration and repair
    Stephen W.P. Kemp, Sarah K. Walsh, Rajiv Midha · 2008 · Neurological Research
  85. Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
    Antonino Cattaneo, Pietro Calissano · 2012 · Molecular Neurobiology
  86. Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats
    Lili Tian, Ruibing Guo, Xuanye Yue, Qiushi Lv, Xinchun Ye, Zhenzhen Wang, Zhaoyao Chen, Bo Wu, Gelin Xu, Xinfeng Liu · 2012 · Brain Research
  87. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
    Marguerite Prior, Richard Dargusch, Jennifer L. Ehren, Chandramouli Chiruta, David A. Schubert · 2013 · Alzheimer s Research & Therapy
  88. Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease
    Pietro Calissano, Carmela Matrone, Giuseppina Amadoro · 2010 · Developmental Neurobiology
  89. Current Treatment and Recent Clinical Research in Alzheimer's Disease
    Judith A. Neugroschl, Mary Sano · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  90. Differentiation by nerve growth factor (NGF) involves mechanisms of crosstalk between energy homeostasis and mitochondrial remodeling
    Francesca Martorana, Daniela Gaglio, Maria Rosaria Bianco, Federica Aprea, Assunta Virtuoso, Marcella Bonanomi, Lilia Alberghina, Michèle Papa, Anna Maria Colangelo · 2018 · Cell Death and Disease
  91. Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
    Raymond T. Bartus, Jeffrey H. Kordower, Eugene M. Johnson, Lamar Brown, Brian R. Kruegel, Yaping Chu, Tiffany L. Baumann, Anthony Edward Lang, C. Warren Olanow, Christopher D. Herzog · 2015 · Neurobiology of Disease
  92. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer’s disease
    Célia M. C. Faustino, Patrícia Mendonca Rijo, Catarina Pinto Reis · 2017 · Pharmacological Research
  93. Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer Disease
    Paul S. S. Aisen, Jeffrey L. Cummings, L. S. Schneider · 2011 · Cold Spring Harbor Perspectives in Medicine
  94. Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer’s Disease via Enhancing Neuron Differentiation and Paracrine Action
    Guo-hong Cui, Shui-jin Shao, Jiajun Yang, Jian‐Ren Liu, Hai-dong Guo · 2015 · Molecular Neurobiology
  95. The Nerve Growth Factor Signaling and Its Potential as Therapeutic Target for Glaucoma
    Haitao Wang, Rikang Wang, Thilini Rasika Thrimawithana, Peter J. Little, Jiangping Xu, Zhong‐Ping Feng, Wenhua Zheng · 2014 · BioMed Research International
  96. Nerve growth factor in treatment and pathogenesis of Alzheimer's disease
    Brice J. Williams, Maria Eriksdotter, Ann‐Charlotte Granholm · 2006 · Progress in Neurobiology
  97. Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery
    Alan H. Nagahara, Tim Bernot, Rod Moseanko, Laurie L. Brignolo, Armin Blesch, James M. Conner, Anthony Ramirez, Mehdi Gasmi, Mark H. Tuszynski · 2008 · Experimental Neurology
  98. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
    Perez, Sylvia E., He, Bin, Muhammad, Nadeem, Oh, Kwang-Jin, Fahnestock, Margaret, Ikonomovic, Milos D., Mufson, Elliott J. · 2011 · Neurobiology of Disease
  99. Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
    Robert D. Wyse, Gary Leo Dunbar, Julien Rossignol · 2014 · International Journal of Molecular Sciences
  100. A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease
    Sachiko Murase, Ronald D.G. McKay · 2006 · Journal of Neuroscience